Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
US9532945B2 · kind B2 · utility
0Cited by
13References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2008 |
| Grant date | Jan 3, 2017 |
| Priority date | — |
| Expiry date | Sep 26, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides oral dosage forms comprising an antiplatelet agent and an enterically coated acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an enterically coated acid inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.